Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real‐world study

It is necessary to develop prognostic tools of metastatic pancreatic cancer (MPC) for optimizing therapeutic strategies. Thus, we tried to develop and validate a prognostic nomogram of MPC. Data from 3 clinical trials (NCT00844649, NCT01124786, and NCT00574275) and 133 Chinese MPC patients were used...

Descripción completa

Detalles Bibliográficos
Autores principales: Hang, Junjie, Wu, Lixia, Zhu, Lina, Sun, Zhiqiang, Wang, Ge, Pan, Jingjing, Zheng, Suhua, Xu, Kequn, Du, Jiadi, Jiang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051216/
https://www.ncbi.nlm.nih.gov/pubmed/29856121
http://dx.doi.org/10.1002/cam4.1573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051216/
https://www.ncbi.nlm.nih.gov/pubmed/29856121
http://dx.doi.org/10.1002/cam4.1573

Ejemplares similares